Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
138
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Obesity Promotes Tumor Immune Evasion in Ovarian Cancer Through Increased Production of Myeloid-Derived Suppressor Cells via IL-6

Qiannan Yang1 Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, People’s Republic of China
,
Bojun Yu1 Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, People’s Republic of China
,
Jiuhong Kang2 Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Science and Technology, Institute for Advanced Study, Tongji University, Shanghai, 200092, People’s Republic of China
,
Ang Li2 Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Science and Technology, Institute for Advanced Study, Tongji University, Shanghai, 200092, People’s Republic of ChinaCorrespondence[email protected]
&
Jing Sun1 Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1183-1742
ORCID Icon
Pages 7355-7363 | Published online: 21 Sep 2021

References

  • SiegelRL, MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
  • TorreLA, TrabertB, DeSantisCE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–296. doi:10.3322/caac.2145629809280
  • KimB, KimHS, KimS, et al. Adipose stromal cells from visceral and subcutaneous fat facilitate migration of ovarian cancer cellS via IL-6/JAK2/STAT3 pathway. Cancer Res Treat. 2017;49(2):338–349. doi:10.4143/crt.2016.17527456942
  • SolitoS, PintonL, DamuzzoV, MandruzzatoS. Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses. Immunol Invest. 2012;41(6–7):722–737. doi:10.3109/08820139.2012.67802323017143
  • GabrilovichDI, Ostrand-RosenbergS, BronteV. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12(4):253–268. doi:10.1038/nri317522437938
  • CuiTX, KryczekI, ZhaoL, et al. Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity. 2013;39(3):611–621. doi:10.1016/j.immuni.2013.08.02524012420
  • GaoJ, AksoyBA, DogrusozU, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi:10.1126/scisignal.200408823550210
  • QuailDF, OlsonOC, BhardwajP, et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat Cell Biol. 2017;19(8):974–987. doi:10.1038/ncb357828737771
  • IyengarNM, GucalpA, DannenbergAJ, HudisCA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270–4276. doi:10.1200/JCO.2016.67.428327903155
  • ChoU, KimB, KimS, HanY, SongYS. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-kappaB activation. Mol Carcinog. 2018;57(2):235–242. doi:10.1002/mc.2275029024042
  • GrothC, HuX, WeberR, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120(1):16–25. doi:10.1038/s41416-018-0333-130413826
  • PrendergastGC, MalachowskiWJ, MondalA, ScherleP, MullerAJ. Indoleamine 2,3-dioxygenase and its therapeutic inhibition in cancer. Int Rev Cell Mol Biol. 2018;336:175–203.29413890
  • OhlK, TenbrockK. Reactive oxygen species as regulators of MDSC-mediated immune suppression. Front Immunol. 2018;9:2499. doi:10.3389/fimmu.2018.0249930425715
  • LuC, ReddPS, LeeJR, SavageN, LiuK. The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells. Oncoimmunology. 2016;5(12):e1247135. doi:10.1080/2162402X.2016.124713528123883
  • ConsonniFM, PortaC, MarinoA, et al. Myeloid-derived suppressor cells: ductile targets in disease. Front Immunol. 2019;10:949. doi:10.3389/fimmu.2019.0094931130949
  • ZhangH, LiZ, WangL, et al. Critical role of myeloid-derived suppressor cells in tumor-induced liver immune suppression through inhibition of NKT cell function. Front Immunol. 2017;8:129.28243237
  • SinghR, StockardCR, GrizzleWE, LillardJWJr, SinghS. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. Int J Oncol. 2011;39:373–381.21637913
  • HongIS. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types. Exp Mol Med. 2016;48(7):e242. doi:10.1038/emm.2016.6427364892
  • DouganM, DranoffG, DouganSK. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 2019;50(4):796–811. doi:10.1016/j.immuni.2019.03.02230995500
  • LutgendorfSK, WeinribAZ, PenedoF, et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol. 2008;26(29):4820–4827. doi:10.1200/JCO.2007.14.197818779606
  • MaccioA, MadedduC. Inflammation and ovarian cancer. Cytokine. 2012;58(2):133–147. doi:10.1016/j.cyto.2012.01.01522349527
  • IliottaLA, AbeS, RobeyPG, MartinGR. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Nati Acad Sci USA. 1979;76(5):2268–2272. doi:10.1073/pnas.76.5.2268
  • WuD, HuD, ChenH, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018;559:637–641. doi:10.1038/s41586-018-0350-530022161
  • KarakhanovaS, LinkJ, HeinrichM, et al. Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells. Oncoimmunology. 2015;4:e998519. doi:10.1080/2162402X.2014.99851926137414
  • PopVV, SeiceanA, LupanI, SamascaG, BurzCC. IL-6 roles - molecular pathway and clinical implication in pancreatic cancer - A systemic review. Immunol Lett. 2017;181:45–50. doi:10.1016/j.imlet.2016.11.01027876525

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.